Popular Articles

AccuVein Vein Illuminator Receives European CE Mark
AccuVein LLC, maker of the AV300, the world"s first hand-held, non-contact vein illumination device, announced today that its medical device now carries a CE Mark, enabling the Company to commence European sales of AccuVein"s AV300.
pharmacy online
Second Gene Linked To Familial Testicular Cancer
Specific variations or mutations in a particular can gene raise a man"s risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease, according to new research by scientists at the National Institutes of Health. This is only the second gene to be identified that affects the risk of familial testicular cancer, and the first gene in a key biochemical pathway. The study appears in the July 2009 Cancer Research.
News of the day
Family Drug Support's 'Stepping Stones To Success' Wins At The 2009 National Drug And Alcohol Awards
Family Drug Support"s Stepping Stones to Success program has won the 2009 National Drug and Alcohol Award for Excellence in Prevention and Community Education.
Sexual Health

Vaginal Ring Could Protect Against HIV, Researcher Says

A researcher with Weill Cornell Medical College has developed a vaginal ring that releases microbicides and could prevent HIV and unplanned pregnancies, ANI/Times of India reports. Brij Saxena -- a professor of reproductive biology and endocrinology and lead author of a recent study on the ring in the journal AIDS -- said that laboratory testing showed the device would be effective at preventing HIV infection and pregnancy by releasing several types of nonhormonal agents and microbicides. He added that if proven successful in clinical trials, the device would allow women to effectively protect themselves from HIV and avoid pregnancy. According to Saxena, the ring releases antiretroviral drugs over a period of 28 days. He noted that the device potentially could serve as an alternative method to prevent other sexually transmitted infections. Jeffrey Laurence, co-author of the study and a physician at New York Presbyterian Hospital-Weill Cornell Medical Center, said, "No one has ever conquered a viral epidemic with treatment, so prevention is the most effective option." He added, "Ideally, an HIV vaccine is the most desirable method, but that is not foreseeable in the near future. The next best thing would be something that would prevent infection and put the power in the susceptible female partner"s control. That"s the potential a device such as this can offer" (ANI/Times of India, 5/20). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):